Apremilast

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Mylan’s President, Emcure’s CEO named in US drug price-fixing probe; Novartis buys French biotech for US$ 3.9 billion

This week in Phispers, we look at how Mylan’s president Rajiv Malik and Emcure’s CEO Sat

India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017

A review of the Drug Master Files (DMFs) submitted to the United States Food and Drug Administration

US DMF filings indicate a robust API industry, with multiple first-to-file challenges

This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at